The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Malhotra, D., Thimmulappa, R., Navas-Acien, A., Sandford, A., Elliott, M., Singh, A., Chen, L., Zhuang, X., Hogg, J., Pare, P., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-380oc · Cited by 357
RetractedMalhotra, D., Thimmulappa, R. K., Mercado, N., Ito, K., Kombairaju, P., Kumar, S., Ma, J., Feller-Kopman, D. J., Wise, R. A., Barnes, P. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45144 · Cited by 137
Self-citationRetractedThe Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782
Fitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
Gan, W. Q. (2004) · Thorax · doi:10.1136/thx.2003.019588 · Cited by 1,838
Airway Mucus Function and Dysfunction
Fahy, J. V., & Dickey, B. F. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0910061 · Cited by 1,722
Immunology of asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2254 · Cited by 1,399
Self-citationChronic obstructive pulmonary disease in non-smokers
Salvi, S. S., & Barnes, P. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61303-9 · Cited by 1,368
Self-citationKeatings, V. M., Collins, P. D., Scott, D. M., & Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564092 · Cited by 1,362
Self-citationSmall-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease
McDonough, J. E., Yuan, R., Suzuki, M., Seyednejad, N., Elliott, W. M., Sanchez, P. G., Wright, A. C., Gefter, W. B., Litzky, L., Coxson, H. O., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106955 · Cited by 1,207
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Self-citationThe cytokine network in asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36130 · Cited by 982
Self-citationDecreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
Ito, K., Ito, M., Elliott, W. M., Cosio, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I. M., Hogg, J. C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041892 · Cited by 968
Self-citationMaresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908 · cited 1×
“Maresin-1 is the most potent proresolving mediator that stimulates macrophage efferocytosis so a stable analogue of this mediator may be useful in COPD.(105)”
BackgroundAgustí, A., Edwards, L. D., Rennard, S. I., MacNee, W., Tal-Singer, R., Miller, B. E., Vestbo, J., Lomas, D. A., Calverley, P. M. A., Wouters, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037483 · Cited by 848
Immunologic Aspects of Chronic Obstructive Pulmonary Disease
Cosio, M. G., Saetta, M., & Agusti, A. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804752 · Cited by 815
Galbán, C. J., Han, M. K., Boes, J. L., Chughtai, K. A., Meyer, C. R., Johnson, T. D., Galbán, S., Rehemtulla, A., Kazerooni, E. A., Martinez, F. J., et al. (2012) · Nature Medicine · doi:10.1038/nm.2971 · Cited by 813
New insights into the immunology of chronic obstructive pulmonary disease
Brusselle, G. G., Joos, G. F., & Bracke, K. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60988-4 · Cited by 776
Systemic oxidative stress in asthma, COPD, and smokers
Rahman, I., Morrison, D., Donaldson, K., & MacNee, W. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887607 · Cited by 774
Isoprostanes: markers and mediators of oxidative stress
Montuschi, P., Barnes, P. J., & Roberts, L. J. (2004) · The FASEB Journal · doi:10.1096/fj.04-2330rev · Cited by 747
Self-citationCachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
Tracey, K. J., Wei, H., Manogue, K. R., Fong, Y., Hesse, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., & Cerami, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.3.1211 · Cited by 730
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
Bhowmik, A. (2000) · Thorax · doi:10.1136/thorax.55.2.114 · Cited by 730
Mediators of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.2 · Cited by 710
Self-citationKirkham, P. A., & Barnes, P. J. (2013) · Chest · doi:10.1378/chest.12-2664 · Cited by 685
Self-citationIto, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050466 · Cited by 638 · cited 1×
“The reduction in HDAC2 also results in increased acetylation of the glucocorticoid receptor, which prevents it from inhibiting NF-kB– driven inflammation.(27) A novel therapeutic strategy is reversal of this corticosteroid resistance through increasing the expression and activity of HDAC2 and this may be achieved with…”
BackgroundSelf-citationCOPD as a Disease of Accelerated Lung Aging
Ito, K., & Barnes, P. J. (2009) · Chest · doi:10.1378/chest.08-1419 · Cited by 629
Self-citationBrightling, C. E., Monteiro, W., Ward, R., Parker, D., Morgan, M. D., Wardlaw, A. J., & Pavord, I. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02872-5 · Cited by 595
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Keatings, V. M., Jatakanon, A., Worsdell, Y. M., & Barnes, P. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032192 · Cited by 558
Self-citationC-reactive Protein As a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease
Dahl, M., Vestbo, J., Lange, P., Bojesen, S. E., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-713oc · Cited by 543
Airway eosinophilia in chronic bronchitis during exacerbations.
Saetta, M., Di Stefano, A., Maestrelli, P., Turato, G., Ruggieri, M. P., Roggeri, A., Calcagni, P., Mapp, C. E., Ciaccia, A., & Fabbri, L. M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.6.7952628 · Cited by 536
Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice
Petrache, I., Natarajan, V., Zhen, L., Medler, T. R., Richter, A. T., Cho, C., Hubbard, W. C., Berdyshev, E. V., & Tuder, R. M. (2005) · Nature Medicine · doi:10.1038/nm1238 · Cited by 510
Grumelli, S., Corry, D. B., Song, L.-Z., Song, L., Green, L., Huh, J., Hacken, J., Espada, R., Bag, R., Lewis, D. E., et al. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010008 · Cited by 484 · cited 2×
“Macrophages also release CXCL9, CXCL10, and CXCL11, which are chemotactic for CD8(1) Tc1 and CD4(1) Th1 cells, via interaction with the chemokine receptor CXCR3 expressed on these cells.(23) Macrophages from patients with COPD release more inflammatory proteins than macrophages from normal smokers and nonsmokers, indi…”
BackgroundAirway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
Donaldson, G. C., Seemungal, T. A. R., Patel, I. S., Bhowmik, A., Wilkinson, T. M. A., Hurst, J. R., MacCallum, P. K., & Wedzicha, J. A. (2005) · Chest · doi:10.1378/chest.128.4.1995 · Cited by 480
Spruit, M. A. (2003) · Thorax · doi:10.1136/thorax.58.9.752 · Cited by 476
Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages
Cosio, B. G., Tsaprouni, L., Ito, K., Jazrawi, E., Adcock, I. M., & Barnes, P. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040416 · Cited by 473
Self-citationAARON, S. D., ANGEL, J. B., LUNAU, M., WRIGHT, K., FEX, C., LE SAUX, N., & DALES, R. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2003122 · Cited by 466
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Perera, W. R., Wilkinson, T. M. A., Bilello, J. A., Hagan, G. W., Vessey, R. S., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-506oc · Cited by 454
Hodge, S., Hodge, G., Scicchitano, R., Reynolds, P. N., & Holmes, M. (2003) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2003.t01-1-01170.x · Cited by 440 · cited 1×
“COPD macrophages are also defective in taking up apoptotic cells and this may contribute to the failure to resolve inflammation in COPD.(30) The nature of this defect in phagocytosis is not fully understood, but it seems to be caused by a defect in microtubular function that is required for phagocytosis rather than an…”
BackgroundNovel Lipid Mediators and Resolution Mechanisms in Acute Inflammation
Serhan, C. N. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100322 · Cited by 421
The Cytokine Network in Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0220tr · Cited by 412
Self-citationKeatings, V. M., & Barnes, P. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032177 · Cited by 402
Self-citationExpression of the T Helper 17-Associated Cytokines IL-17A and IL-17F in Asthma and COPD
Doe, C., Bafadhel, M., Siddiqui, S., Desai, D., Mistry, V., Rugman, P., McCormick, M., Woods, J., May, R., Sleeman, M. A., et al. (2010) · Chest · doi:10.1378/chest.09-3058 · Cited by 394
New anti-inflammatory targets for chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4025 · Cited by 392
Self-citationIncreased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD
Traves, S. L. (2002) · Thorax · doi:10.1136/thorax.57.7.590 · Cited by 377
Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema
Majo, J., Ghezzo, H., & Cosio, M. G. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17509460 · Cited by 374
Inflammatory changes, recovery and recurrence at COPD exacerbation
Perera, W. R., Hurst, J. R., Wilkinson, T. M. A., Sapsford, R. J., Müllerova, H., Donaldson, G. C., & Wedzicha, J. A. (2007) · European Respiratory Journal · doi:10.1183/09031936.00092506 · Cited by 372
Saetta, M., Mariani, M., Panina-Bordignon, P., Turato, G., Buonsanti, C., Baraldo, S., Bellettato, C. M., Papi, A., Corbetta, L., Zuin, R., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107139 · Cited by 372
Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms
Donnelly, L. E., Newton, R., Kennedy, G. E., Fenwick, P. S., Leung, R. H. F., Ito, K., Russell, R. E. K., & Barnes, P. J. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00110.2004 · Cited by 361
Self-citationAlveolar Macrophages as Orchestrators of COPD
Barnes, P. J. (2004) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-120028701 · Cited by 360
Self-citationDefective macrophage phagocytosis of bacteria in COPD
Taylor, A. E., Finney-Hayward, T. K., Quint, J. K., Thomas, C. M. R., Tudhope, S. J., Wedzicha, J. A., Barnes, P. J., & Donnelly, L. E. (2010) · European Respiratory Journal · doi:10.1183/09031936.00036709 · Cited by 359
Self-citationTo, Y., Ito, K., Kizawa, Y., Failla, M., Ito, M., Kusama, T., Elliott, W. M., Hogg, J. C., Adcock, I. M., & Barnes, P. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0937oc · Cited by 352
Self-citationDi Stefano, A., Caramori, G., Gnemmi, I., Contoli, M., Vicari, C., Capelli, A., Magno, F., D'Anna, S. E., Zanini, A., Brun, P., et al. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03965.x · Cited by 336
Self-citationElevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients.
de Godoy, I., Donahoe, M., Calhoun, W. J., Mancino, J., & Rogers, R. M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564110 · Cited by 334
Culpitt, S. V., Rogers, D. F., Shah, P., De Matos, C., Russell, R. E. K., Donnelly, L. E., & Barnes, P. J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-298oc · Cited by 333
Self-citationTAKABATAKE, N., NAKAMURA, H., ABE, S., INOUE, S., HINO, T., SAITO, H., YUKI, H., KATO, S., & TOMOIKE, H. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9903022 · Cited by 327
Role of HDAC2 in the Pathophysiology of COPD
Barnes, P. J. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163257 · Cited by 318
Self-citationde BOER, W. I., van SCHADEWIJK, A., SONT, J. K., SHARMA, H. S., STOLK, J., HIEMSTRA, P. S., & van KRIEKEN, J. H. J. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9803053 · Cited by 314
Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease
Barnes, P. J., Chowdhury, B., Kharitonov, S. A., Magnussen, H., Page, C. P., Postma, D., & Saetta, M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1659pp · Cited by 298
Self-citationRussell, R. E. K., Thorley, A., Culpitt, S. V., Dodd, S., Donnelly, L. E., Demattos, C., Fitzgerald, M., & Barnes, P. J. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00020.2002 · Cited by 296
Self-citationExhaled leukotrienes and prostaglandins in COPD
Montuschi, P. (2003) · Thorax · doi:10.1136/thorax.58.7.585 · Cited by 293
Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A
Cheng, N., He, R., Tian, J., Ye, P. P., & Ye, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.22 · Cited by 284
Rennard, S. I., Calverley, P. M., Goehring, U. M., Bredenbröker, D., & Martinez, F. J. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-18 · Cited by 284
PAPI, A., ROMAGNOLI, M., BARALDO, S., BRACCIONI, F., GUZZINATI, I., SAETTA, M., CIACCIA, A., & FABBRI, L. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.9910112 · Cited by 280
Biernacki, W. A. (2003) · Thorax · doi:10.1136/thorax.58.4.294 · Cited by 276
Telomere Dysfunction Causes Sustained Inflammation in Chronic Obstructive Pulmonary Disease
Amsellem, V., Gary-Bobo, G., Marcos, E., Maitre, B., Chaar, V., Validire, P., Stern, J.-B., Noureddine, H., Sapin, E., Rideau, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0802oc · Cited by 264
Serum Amyloid A Is a Biomarker of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Bozinovski, S., Hutchinson, A., Thompson, M., MacGregor, L., Black, J., Giannakis, E., Karlsson, A.-S., Silvestrini, R., Smallwood, D., Vlahos, R., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-678oc · Cited by 260
DAHL, M., TYBJŒRG-HANSEN, A., VESTBO, J., LANGE, P., & NORDESTGAARD, B. G. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2010067 · Cited by 260
Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights
Adcock, I. M., Caramori, G., & Barnes, P. J. (2011) · Respiration · doi:10.1159/000324601 · Cited by 257 · cited 1×
“Oxidative stress may also predispose to lung cancer, through the activation of growth factors and via DNA damage.(76) Oxidative stress leads to formation of carbonylated proteins, which may be antigenic and stimulate the development of autoantibodies in patients with COPD.”
BackgroundSelf-citationInflammatory Biomarkers and Comorbidities in Chronic Obstructive Pulmonary Disease
Thomsen, M., Dahl, M., Lange, P., Vestbo, J., & Nordestgaard, B. G. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201206-1113oc · Cited by 245
Neutrophil Chemotactic Activity of Sputum From Patients With COPD
Beeh, K. M., Kornmann, O., Buhl, R., Culpitt, S. V., Giembycz, M. A., & Barnes, P. J. (2003) · Chest · doi:10.1378/chest.123.4.1240 · Cited by 233
Self-citationInhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD
Culpitt, S. V. (2003) · Thorax · doi:10.1136/thorax.58.11.942 · Cited by 226
A protein deacetylase SIRT1 is a negative regulator of metalloproteinase‐9
Nakamaru, Y., Vuppusetty, C., Wada, H., Milne, J. C., Ito, M., Rossios, C., Elliot, M., Hogg, J., Kharitonov, S., Goto, H., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-125468 · Cited by 225
Self-citationPhosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
Chong, J., Leung, B., & Poole, P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002309.pub5 · Cited by 218
Caramori, G. (2003) · Thorax · doi:10.1136/thorax.58.4.348 · Cited by 216
Interleukin-6 Causes Myocardial Failure and Skeletal Muscle Atrophy in Rats
Janssen, S. P. M., Gayan-Ramirez, G., Van Den Bergh, A., Herijgers, P., Maes, K., Verbeken, E., & Decramer, M. (2005) · Circulation · doi:10.1161/01.cir.0000156469.96135.0d · Cited by 209
Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress
Mercado, N., Thimmulappa, R., Thomas, C. M. R., Fenwick, P. S., Chana, K. K., Donnelly, L. E., Biswal, S., Ito, K., & Barnes, P. J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.035 · Cited by 209
Self-citationCurcumin Restores Corticosteroid Function in Monocytes Exposed to Oxidants by Maintaining HDAC2
Meja, K. K., Rajendrasozhan, S., Adenuga, D., Biswas, S. K., Sundar, I. K., Spooner, G., Marwick, J. A., Chakravarty, P., Fletcher, D., Whittaker, P., et al. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0012oc · Cited by 206
ZHU, J., QIU, Y. S., MAJUMDAR, S., GAMBLE, E., MATIN, D., TURATO, G., FABBRI, L. M., BARNES, N., SAETTA, M., & JEFFERY, P. K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.1.2007050 · Cited by 203
Chronic Obstructive Pulmonary Disease: Effects beyond the Lungs
Barnes, P. J. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000220 · Cited by 197
Self-citationThe natural history of community-acquired pneumonia in COPD patients: A population database analysis
Müllerova, H., Chigbo, C., Hagan, G. W., Woodhead, M. A., Miravitlles, M., Davis, K. J., & Wedzicha, J. A. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.04.008 · Cited by 197
Treatment Effects of Low-Dose Theophylline Combined With an Inhaled Corticosteroid in COPD
Ford, P. A., Durham, A. L., Russell, R. E. K., Gordon, F., Adcock, I. M., & Barnes, P. J. (2010) · Chest · doi:10.1378/chest.09-2363 · Cited by 190
Self-citationDefective Phagocytosis in Airways Disease
Donnelly, L. E., & Barnes, P. J. (2012) · Chest · doi:10.1378/chest.11-2348 · Cited by 190
Self-citationKirkham, P. A., Caramori, G., Casolari, P., Papi, A. A., Edwards, M., Shamji, B., Triantaphyllopoulos, K., Hussain, F., Pinart, M., Khan, Y., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1605oc · Cited by 186
Self-citationSystemic inflammation and decline in lung function in a general population: a prospective study
Fogarty, A. W., Jones, S., Britton, J. R., Lewis, S. A., & McKeever, T. M. (2007) · Thorax · doi:10.1136/thx.2006.066969 · Cited by 184
Sapey, E., Stockley, J. A., Greenwood, H., Ahmad, A., Bayley, D., Lord, J. M., Insall, R. H., & Stockley, R. A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201008-1285oc · Cited by 175
Tuder, R. M., Yoshida, T., Arap, W., Pasqualini, R., & Petrache, I. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200603-054ms · Cited by 174
C-Reactive Protein Levels and Survival in Patients With Moderate to Very Severe COPD
de Torres, J. P., Pinto-Plata, V., Casanova, C., Mullerova, H., Córdoba-Lanús, E., de Fuentes, M. M., Aguirre-Jaime, A., & Celli, B. R. (2008) · Chest · doi:10.1378/chest.07-2433 · Cited by 169
Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2
Traves, S. L., Smith, S. J., Barnes, P. J., & Donnelly, L. E. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003495 · Cited by 169
Self-citationChronic Obstructive Pulmonary Disease: A Chronic Systemic Inflammatory Disease
van Eeden, S. F., & Sin, D. D. (2007) · Respiration · doi:10.1159/000111820 · Cited by 168
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Gamble, E., Grootendorst, D. C., Hattotuwa, K., O'Shaughnessy, T., Ram, F. S. F., Qiu, Y., Zhu, J., Vignola, A. M., Kroegel, C., Morell, F., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00013006 · Cited by 168
CXCR3 and CCR5 Chemokines in Induced Sputum From Patients With COPD
Costa, C., Rufino, R., Traves, S. L., Lapa e Silva, J. R., Barnes, P. J., & Donnelly, L. E. (2008) · Chest · doi:10.1378/chest.07-0393 · Cited by 165
Self-citationBozinovski, S., Uddin, M., Vlahos, R., Thompson, M., McQualter, J. L., Merritt, A.-S., Wark, P. A. B., Hutchinson, A., Irving, L. B., Levy, B. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109382109 · Cited by 163
Increased Systemic Inflammation Is a Risk Factor for COPD Exacerbations
Groenewegen, K. H., Postma, D. S., Hop, W. C. J., Wielders, P. L. M. L., Schlösser, N. J. J., & Wouters, E. F. M. (2008) · Chest · doi:10.1378/chest.07-1342 · Cited by 160
Emphysematous Lung Destruction by Cigarette Smoke
Meshi, B., Vitalis, T. Z., Ionescu, D. N., Elliott, W. M., Liu, C., Wang, X., Hayashi, S., & Hogg, J. C. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.1.4253 · Cited by 158
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
Stefano, A. D., Caramori, G., Capelli, A., Gnemmi, I., Ricciardolo, F. L. M., Oates, T. M., Donner, C. F., Chung, K. F., Barnes, P. J., & Adcock, I. M. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00080303 · Cited by 144
Self-citationSoluble RAGE is deficient in neutrophilic asthma and COPD
Sukkar, M. B., Wood, L. G., Tooze, M., Simpson, J. L., McDonald, V. M., Gibson, P. G., & Wark, P. A. B. (2011) · European Respiratory Journal · doi:10.1183/09031936.00022011 · Cited by 138
Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease
Donnelly, L., & Barnes, P. J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.08.001 · Cited by 137
Self-citationThe effect of oxidative stress on histone acetylation and IL-8 release
Tomita, K., Barnes, P. J., & Adcock, I. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03029-2 · Cited by 131
Self-citationComprehensive characterisation of pulmonary and serum surfactant protein D in COPD
Winkler, C., Atochina‐Vasserman, E. N., Holz, O., Beers, M. F., Erpenbeck, V. J., Krug, N., Roepcke, S., Lauer, G., Elmlinger, M. W., & Hohlfeld, J. M. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-29 · Cited by 126
Saetta, M. P., Stefano, A. D., Maestrelli, P., Turato, G., Mapp, C., Pieno, M., ZANGUOCHI, G., Prete, G. D., & Fabbri, L. M. (1996) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1996.tb00606.x · Cited by 123
Sin, D. D., Leung, R., Gan, W., & Man, S. P. (2007) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-7-13 · Cited by 123
Brindicci, C., Kharitonov, S. A., Ito, M., Elliott, M. W., Hogg, J. C., Barnes, P. J., & Ito, K. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200904-0493oc · Cited by 123
Self-citationFreeman, C. M., Martínez, F. J., Han, M. K., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200904-0552oc · Cited by 121
de Boer, W. I., Hau, C. M., van Schadewijk, A. M., Stolk, J. N., van Krieken, J. H. J. M., & Hiemstra, P. S. (2005) · American Journal of Clinical Pathology · doi:10.1309/w1ax-kgt7-ua37-x257 · Cited by 120
New drugs for exacerbations of chronic obstructive pulmonary disease
Hansel, T. T., & Barnes, P. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61342-8 · Cited by 117
Self-citationN-α-PGP and PGP, potential biomarkers and therapeutic targets for COPD
O’Reilly, P. J., Jackson, P. L., Noerager, B. D., Parker, S. B., Dransfield, M. T., Gaggar, A., & Blalock, J. E. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-38 · Cited by 115
Pathogenesis and Pathology of COPD
Turato, G., Zuin, R., & Saetta, M. P. (2001) · Respiration · doi:10.1159/000050478 · Cited by 109
Broekhuizen, R., Grimble, R. F., Howell, W. M., Shale, D. J., Creutzberg, E. C., Wouters, E. F. �., & Schols, A. M. W. J. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.5.1059 · Cited by 108
The role of the NLRP3 Inflammasome in the pathogenesis of airway disease
Birrell, M. A., & Eltom, S. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.007 · Cited by 105
Selective accumulation of langerhans-type dendritic cells in small airways of patients with COPD
Pottelberge, G. R. V., Bracke, K. R., Demedts, I., Rijck, K. D., Reinartz, S. M., van Drunen, C. M., Verleden, G. M., Vermassen, F. E. G., Joos, G., & Brusselle, G. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-35 · Cited by 94
Nortriptyline Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ
Mercado, N., To, Y., Ito, K., & Barnes, P. J. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175950 · Cited by 87
Self-citationPeroxynitrite Elevation in Exhaled Breath Condensate of COPD and Its Inhibition by Fudosteine
Osoata, G. O., Hanazawa, T., Brindicci, C., Ito, M., Barnes, P. J., Ito, K., & Ito, K. (2009) · CHEST Journal · doi:10.1378/chest.08-2105 · Cited by 86
Self-citationKobayashi, Y., Wada, H., Rossios, C., Takagi, D., Charron, C. E., Barnes, P. J., & Ito, K. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12187 · Cited by 82
Self-citationHodge, G. L., Mukaro, V. R., Reynolds, P. N., & Hodge, S. J. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04455.x · Cited by 81
Lambers, C., Hacker, S., Posch, M., Höetzenecker, K., Pollreisz, A., Lichtenauer, M., Klepetko, W., & Ankersmit, H. J. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03835.x · Cited by 76
Endothelin in Pulmonary Fibrosis
Fonseca, C., Abraham, D., & Renzoni, E. A. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0388tr · Cited by 72
Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro
Liu, H., Lazarus, S. C., Caughey, G. H., & Fahy, J. V. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.1.l28 · Cited by 68
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
Chong, J., Poole, P., Leung, B., & Black, P. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002309.pub3 · Cited by 63
Antiendothelial Cell Antibodies in Patients With COPD
Karayama, M., Inui, N., Suda, T., Nakamura, Y., Nakamura, H., & Chida, K. (2010) · CHEST Journal · doi:10.1378/chest.10-0863 · Cited by 59
The Antifibrogenic Potential of PPARγ Ligands in Pulmonary Fibrosis
Sime, P. J. (2008) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31816464e9 · Cited by 55
Regulation of IL-17 in chronic inflammation in the human lung
Pridgeon, C., Bugeon, L., Donnelly, L., Straschil, U., Tudhope, S. J., Fenwick, P. S., Lamb, J. R., Barnes, P. J., & Dallman, M. J. (2011) · Clinical Science · doi:10.1042/cs20100417 · Cited by 55
Self-citationTissue macrophage heterogeneity: issues and prospects
Gordon, S., & Plüddemann, A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0386-4 · Cited by 50
Aging and TOR: interwoven in the fabric of life
Sharp, Z. D. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0542-0 · Cited by 37
The Role of Dendritic Cells in the Pathogenesis of COPD: Liaison Officers in the Front Line
Pottelberge, G. R. V., Bracke, K. R., Joos, G., & Brusselle, G. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550903049124 · Cited by 36
Cited by
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
Barnes, P. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.011 · Cited by 1,683
Self-citationThe sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
Chronic obstructive pulmonary disease
Barnes, P. J., Burney, P. G. J., Silverman, E. K., Celli, B. R., Vestbo, J., Wedzicha, J. A., & Wouters, E. F. M. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.76 · Cited by 734
Self-citationMitochondria in health, disease, and aging
Harrington, J. S., Ryter, S. W., Plataki, M., Price, D. R., & Choi, A. M. K. (2023) · Physiological Reviews · doi:10.1152/physrev.00058.2021 · Cited by 602
Cellular and molecular mechanisms of asthma and COPD
Barnes, P. J. (2017) · Clinical Science · doi:10.1042/cs20160487 · Cited by 511
Self-citation
Metadata
- Authors
- Barnes, P. J.
- Venue
- Clinics in Chest Medicine
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 35
- Issue
- 1
- Pages
- 71-86
- ISSN
- 0272-5231 (ISSN-L)
- OpenAlex
- W2013244153
- Cited by
- 488
- References
- 125
- FWCI
- 22.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.